Position in IMCR
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$15,651,769
-$7,202,544 QoQ
Shares Held
519,130
-21.2% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. IMCR ranks #32 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,651,769 | 519,130 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $22,854,313 | 658,436 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $14,946,488 | 411,409 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $14,275,357 | 454,919 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $14,207,894 | 478,864 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $14,834,281 | 502,857 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $17,006,878 | 546,318 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $14,813,724 | 437,112 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $33,618,260 | 517,204 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $33,021,514 | 483,336 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $25,217,482 | 485,886 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $29,006,069 | 483,757 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $22,436,069 | 453,804 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $28,648,169 | 501,983 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $24,702,268 | 526,252 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $11,191,134 | 299,950 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $7,042,795 | 235,545 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $8,027,191 | 234,439 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $6,855,169 | 184,925 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $6,915,950 | 177,105 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $5,260,460 | 123,572 | Shares | Defined | 2021-05-24 | |
| No filing history on record for this holder in this stock. | ||||||